Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Development of a human in vitro blood–brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Laboratoire de la Barrière Hémato-Encéphalique (LBHE); Université d'Artois (UA); Signalisation des facteurs de croissance dans le cancer du sein. Protéomique fonctionnelle; Institut National de la Santé et de la Recherche Médicale (INSERM); Institut pour la recherche sur le cancer de Lille Lille (IRCL); Centre Régional de Lutte contre le Cancer Oscar Lambret Lille (UNICANCER/Lille); Université de Lille-UNICANCER; Institut de Recerca Pediàtrica Hospital Sant Joan de Déu Barcelona, Spain; Hospital Sant Joan de Déu Barcelona; Yamaguchi University Yamaguchi
    • بيانات النشر:
      HAL CCSD
      BioMed Central
    • الموضوع:
      2020
    • Collection:
      Université d'Artois: HAL
    • نبذة مختصرة :
      International audience ; Background: Pediatric diffuse intrinsic pontine glioma (DIPG) represents one of the most devastating and lethal brain tumors in children with a median survival of 12 months. The high mortality rate can be explained by the ineligibility of patients to surgical resection due to the diffuse growth pattern and midline localization of the tumor. While the therapeutic strategies are unfortunately palliative, the blood-brain barrier (BBB) is suspected to be responsible for the treatment inefficiency. Located at the brain capillary endothelial cells (ECs), the BBB has specific properties to tightly control and restrict the access of molecules to the brain parenchyma including chemotherapeutic compounds. However, these BBB specific properties can be modified in a pathological environment, thus modulating brain exposure to therapeutic drugs. Hence, this study aimed at developing a syngeneic human blood-brain tumor barrier model to understand how the presence of DIPG impacts the structure and function of brain capillary ECs.Methods: A human syngeneic in vitro BBB model consisting of a triple culture of human (ECs) (differentiated from CD34 +-stem cells), pericytes and astrocytes was developed. Once validated in terms of BBB phenotype, this model was adapted to develop a blood-brain tumor barrier (BBTB) model specific to pediatric DIPG by replacing the astrocytes by DIPG-007,-013 and-014 cells. The physical and metabolic properties of the BBTB ECs were analyzed and compared to the BBB ECs. The permeability of both models to chemotherapeutic compounds was evaluated. Results: In line with clinical observation, the integrity of the BBTB ECs remained intact until 7 days of incubation. Both transcriptional expression and activity of efflux transporters were not strongly modified by the presence of DIPG. The permeability of ECs to the chemotherapeutic drugs temozolomide and panobinostat was not affected by the DIPG environment.Conclusions: This original human BBTB model allows a better understanding of ...
    • Relation:
      hal-04461924; https://hal.science/hal-04461924; https://hal.science/hal-04461924/document; https://hal.science/hal-04461924/file/Deligne%20et%20al.,%202020.pdf
    • الرقم المعرف:
      10.1186/s12987-020-00198-0
    • الدخول الالكتروني :
      https://hal.science/hal-04461924
      https://hal.science/hal-04461924/document
      https://hal.science/hal-04461924/file/Deligne%20et%20al.,%202020.pdf
      https://doi.org/10.1186/s12987-020-00198-0
    • Rights:
      info:eu-repo/semantics/OpenAccess
    • الرقم المعرف:
      edsbas.7EC54A25